Insider Purchases: Inside the Buy

Tag: COB insider buy

Confident executive in a healthcare setting with rising stock chart, stethoscope shaped like a bullish trend line, and dollar symbols turning into prescription bottles — symbolizing Cigna CEO stock purchase and strong health-care outlook.

CEO/COB at Cigna Is Buying CI. Is He Signaling: Time To Buy?

Cigna’s CEO is buying big — and Wall Street is paying attention. With earnings up, a pharmacy-benefit shake-up underway, and valuations looking healthy, CI might just be the quiet value stock investors have been waiting for. Let’s break it down — and have fun doing it. 😎💊📈

 

Read entire article

Tags: Buy or Sell Cigna Stock, CEO buy, CEO Conviction, CEO insider buying, CEO Insider Purchases, CEO Stock Purchase, CEOBuyIn, CEOConfidence, CI Stock, Cigna, COB insider buy, David Cordani, Dividends & Buybacks, Evernorth, Funanc1al edge, FUNanc1al Humor, Funanc1al investing, Health & Pharma Stocks, Insider Buying, Institutional Ownership, Market Signals, Pharmacy Benefit Managers (PBM), Share Repurchases, Value Investing
Boardroom skyline with five FTI segments feeding a rising EPS line; ‘CEO BUY’ chip and buyback arrows signal insider conviction and capital returns.”

CEO, COB, President All Bought Shares of FTI Consulting (FCN). It’s the Same Person—Still… Should You Buy Too?

FTI Consulting just posted record EPS while its tri-titled chief bought $1.13M of stock and the board added $500M to buybacks. A cycle-balanced franchise that compounds through booms, busts, and boardroom “oh-no’s.”

Read entire article

Tags: Buybacks, CEO buy, CEO Buys, CEO Conviction, CEO insider buying, CEO Stock Purchase, CEOBuyIn, CEOConfidence, COB insider buy, corporate turnarounds, e-discovery, economic consulting, FCN, forensic accounting, FTI Consulting, Funanc1al, Funanc1al Edge, Funanc1al Humor, FUNanc1al Investing, insider buying, professional services, restructuring, stocks to watch, value investing
Playful digital illustration of Ryan Specialty’s executive chairman standing confidently on a skyscraper-sized insurance policy with a cash briefcase, as Wall Street skyline and insurance icons highlight insider buying and institutional support.

Executive Chairman Adds To His Already Huge Stake in Ryan Specialty Holdings. Should You Follow His Lead?

Executive Chairman Patrick Ryan just added $14M to his already massive stake in Ryan Specialty Holdings. With strong revenue growth and heavy institutional backing, is this insurance play worth your portfolio — or is it still too pricey?

 

Read entire article

Tags: Chairman buying, COB insider buy, Funanc1al Edge, Funanc1al Humor, Funanc1al Investing, Growth Investing, growth stocks, insider buying, institutional investors, insurance stocks, investing 2025, Patrick Ryan, RYAN, Ryan Specialty, specialty insurance